Nantes, France, June 14, 2011 – EPEMED, the European Personalised Medicine Association, a European not for profit organisation bringing together global forces in personalised medicine, today announced the appointment of Prof. Christian Bréchot, MD, PhD, as a new member of its Board of Directors.
“We are delighted that Prof. Christian Bréchot has agreed to join EPEMED’s Board of Directors. Christian’s broad and rare experience both in the academic field and in the industry as well as his vision will considerably strengthen the actions of EPEMED’s board of directors”, emphasized Alain Huriez, MD, EPEMED founder and chairman.
“I am honoured to become an EPEMED Board member and pleased to be given this opportunity to contribute to advancing personalised medicine in Europe. By providing education and fostering exchange among healthcare companies, clinicians, and policy makers, EPEMED is helping to make this important breakthrough in patient care more rapidly and widely accessible”, said Christian Bréchot.
Christian Bréchot is currently Vice President at Institut Merieux where he is in charge of Medical and Scientific affairs. Prior to this position he acted as General Director of INSERM, the French National Agency for biomedical research. Previous positions include Professor of Cell Biology and Hepatology, Head of the clinical department of liver diseases at the Necker-Enfants Malades Hospital, Head of a research unit at the Necker Faculty of Medicine, Paris Descartes University, and the Pasteur Institute and Head of the National Reference Centre on viral hepatitis.
Prof. Bréchot holds MD and PhD degrees, has been the member of numerous scientific committees and societies and has received a number of prestigious awards in the field. He is the author of over 350 articles published in medical and scientific journals. His research activities have led him to obtain numerous patents and to contribute to the creation of two biotech companies.
About EPEMED
- EPEMED the European Personalised Medicine Association, www.epemed.org, is an independent, broad and inclusive not-for-profit organisation founded in 2009 and bringing together forces in personalised medicine in the EU.
- A central point of communication for the different parties involved in advancing personalised medicine, EPEMED addresses issues in personalised medicine that confront the industry, regulators, payers & insurers as well as governments in Europe
- EPEMED aims to provide a platform for the harmonisation of personalised medicine development and implementation across Europe, focusing on the role of diagnostics, to make personalised medicine a reality
Specifically, EPEMED provides:
- Education, awareness and promotion of the benefits of personalised medicine
- A forum to share best practices
- Input to policy-makers on relevant legislation
EPEMED has a diverse membership from the diagnostic, pharmaceutical, professional service and academic communities.
Information available at www.epemed.org (regular updates).
Membership conditions available at www.epemed.org & membership@epemed.org
Further information by writing to contact@epemed.org
ALIZE RP
Caroline Carmagnol
+33 (0)6 64 18 99 59 / caroline@alizerp.com
Anne-Sophie Cosquéric
+ 33 (0) 1 41 22 07 32 / anne-sophie@alizerp.com
EPEMED - contact@epemed.org
